Georgia Bio, Nationwide Life Science Leaders Unite To Celebrate Continued Investment In Biotech At New York Stock Exchange

Industry leaders from across the country to ring NYSE closing bell and kick off Biotech Month

FOR IMMEDIATE RELEASE

January 4, 2024, New York, NY – Georgia Bio, the life sciences trade association in Georgia, joined 16 fellow life science trade organizations from across the country yesterday to ring the closing bell at the New York Stock Exchange (NYSE) and kick off national Biotech Month. Maria Thacker-Goethe, immediate past chair for the Council of State Bioscience Associations (CSBA) and President and CEO of Geogia Bio, was among the leaders in attendance at the event, which was held jointly by NewYorkBIO and NYSE to celebrate the link between investment and innovation to best serve patients nationwide.

Council of State Bioscience Associations (CSBA) and the Biotechnology Innovation Organization (BIO) Rings The Closing Bell® The New York Stock Exchange welcomes the Council of State Bioscience Associations (CSBA) and the Biotechnology Innovation Organization (BIO), today, Wednesday, January 3, 2023, in celebration of of Biotechnology Month. To honor the occasion, John Conrad, President of Illinois Biotechnology Innovation Organization (iBIO), and Maria Thacker Goethe, President of Georgia Bio, joined by Michael Harris, Global Head of Capital Markets, NYSE, rings the Closing Bell®. Photo Credit: NYSE
Photo Credit: NYSE

“I’m honored to ring the closing bell at the New York Stock Exchange with the new CSBA chair, John Conrad of iBio,” said Thacker-Goethe. “Joining my colleagues from across the country underscores that collaboration will help us protect and grow the U.S. innovation ecosystem.”

Georgia is poised to be a hub for life sciences. Georgia Bio’s workforce development program guarantees that the State’s workforce will be well-equipped to meet the demands of the expanding life science community. On the investment side, Georgia Bio along with 6 southeast state associations have partnered with Life Science Nation to launch RESI South in Atlanta on March 25. RESI South will mark the first-even life sciences investor event in the region and will connect start-ups and early-stage investors, an opportunity to showcase the state’s numerous investment opportunities.

“Nationwide collaboration is crucial to driving innovation, finding cures, and ultimately improving health outcomes and quality of life for patients,” added Jennifer Hawks Bland, CEO of NewYorkBIO. “As the worldwide epicenter for the financial sector, New York is uniquely positioned as a nexus for connecting the biosciences industry with the capital that makes groundbreaking research and development possible. NewYorkBIO is grateful to NYSE for this opportunity to welcome our colleagues from across the country to Wall Street, as we bring new meaning to ‘ringing in the new year’ and kick off Biotech Month.”

The event is one of several ongoing collaborations between NewYorkBIO and NYSE, who work together to connect New York’s robust investor community with innovative life science organizations of all types and sizes.

“We are thrilled to host NewYorkBIO and life sciences leaders from across the U.S. at the NYSE to ring our Closing Bell in honor of Biotechnology Month,” said Michael Harris, Global Head of Capital Markets at the New York Stock Exchange. “As we continue to see growth in the life sciences industry, the NYSE looks forward to welcoming many more biotech companies to our community of icons and disruptors.”

Maria Thacker-Goethe joined the below leaders from life science organizations across the country:

  • Nick Shipley, Chief Advocacy Officer at BIO
  • Michele Oshman, Vice President for External Affairs at BIO
  • Chris Molineaux, President & CEO of Life Sciences Pennsylvania
  • Debbie Hart, President & CEO of BioNJ
  • Jennifer Hawks Bland, CEO, NewYorkBIO
  • Elyse Blazevich, President & CEO of Colorado BioScience Association
  • Eddie Pauline, President & CEO of Ohio Life Sciences
  • Jodie Gillon, President & CEO of BioCT
  • John Conrad, President & CEO of Illinois Biotechnology Innovation Organization
  • Joni Ekstrum, Executive Director of South Dakota Biotech
  • Kelly Schulz, CEO of Maryland Tech Council
  • Kendalle Burlin O’Connell, President & CEO of MassBio
  • Laura Gunter, President of North Carolina Life Sciences Organization
  • Michael Fleming, President of Delaware BioScience Association
  • Mike Guerra, President & CEO of California Life Sciences

First introduced by President Clinton in 2000, National Biotechnology Month is an opportunity for the nation’s biotech community to come together to recognize the industry’s achievements on behalf of patients around the world. Falling in January, the recognition month is also an opportunity for industry leaders to look ahead to the advancements of the upcoming year.

To capture the closing bell on January 3, refer to NYSE’s website: nyse.com/bell/calendar

About Georgia Bio

Georgia Bio (GaBio) is the state’s most impactful life sciences membership organization, advocating for the sector and its diverse innovation pipeline. For more than 30 years, GaBio has served its members by supporting companies of all sizes, from early-stage innovators and startups to established industry leaders in the fields of biotechnology, pharmaceuticals, and medical technology. GaBio also works closely with universities, academic and research institutions, the investment community, and other critical partners that promote this vibrant sector. GaBio works to shape public policy, improve access to breakthrough technologies, educate lawmakers, provide member programs, strengthens the workforce pipeline, and advance equity within our ecosystem by championing innovative solutions for some of the most pressing challenges of our times. For more information, visit www.gabio.org.

Contact

Jason Rupp, Georgia Bio, jrupp@gabio.org

By Maria Thacker Goethe April 18, 2025
The Science & Community Impacts Mapping Project (SCIMaP) shows how proposed federal funding cuts lead to reduced economic activity and job losses nationwide.
By Sheran Brown April 10, 2025
Georgia Life Sciences Selects Fulton County Schools Innovation Academy Student as the 2025 Georgia BioGENEius Winner Sandy Springs & Rockmart Teens Take Top Honors in Statewide Science Competition Atlanta, GA (April 4, 2025) – Georgia Life Sciences today named Bhavya Alapati , a junior at Fulton County Schools Innovation Academy, as the winner of the 2025 Georgia BioGENEius Challenge, the premier competition for high school students that recognizes outstanding research and innovation in the biotechnology field. Eleven students from across Georgia competed for this year’s title and cash prize. Bhavya’s project investigated a novel method of identifying strokes using a device she created called SpectroStroke, a small-scale spectrophotometer, to detect homocysteine, an amino acid product that is associated with stroke. Bhavya identified the ability of homocysteine to be detected using Ellman’s reagent, which reacts with the free sulfhydryl group on the molecule to produce a yellow color. Bhavya created a wearable patch that contains the Ellman’s reagent. Then, she designed the SpectroStroke to be able to detect the color change when the patch is exposed to elevated levels of homocysteine. Bhavya’s SpectroStroke can detect normal levels of homocysteine up to extremely high levels seen in those experiencing a stroke. The ability to detect a stroke earlier would reduce damage and long-term effects of the condition. A future iteration of the SpectroStroke would include real-time monitoring capabilities to help track changing homocysteine levels. "Supporting and celebrating outstanding research and innovation in biotechnology is vital for the future of science and medicine. The Georgia BioGENEius Challenge not only encourages the brightest young minds to explore their potential but also nurtures the next generation of leaders who will drive groundbreaking advancements in biotechnology,” said Georgia Life Sciences President and CEO Maria Thacker-Goethe. “By recognizing and empowering these students, we are helping to shape a future where innovation thrives and the possibilities for improving lives are endless. Well done, Bhavya!” Georgia Life Sciences also congratulates the Georgia BioGENEius runner-up, Shelby Kendrick , who is a senior at Paulding County High School in Dallas, GA. Shelby’s research investigated the ability of Aspergillus terreus, a fungus found in soil, to degrade pre-treated polypropylene plastic (PP). This fungus has been discovered to produce high concentrations of degrading enzymes and raises the moisture level of its substrate. Shelby isolated the fungus from soil samples and confirmed the species using PCR amplification and DNA barcoding. Samples of polypropylene were pre-treated with 75% ethanol and UV exposure, then placed in a liquid culture of A. terreus in Minimal Salt Medium (MSM) media, and the culture was incubated for 23 days. At the end of the trial period, PP samples were analyzed using Scanning Electron Microscopy. These samples showed changes in their surface layer, indicating evidence of biodegradation. Polypropylene plastic is found in household items such as plastic cups and is a known problem in the environment due to its inability to degrade. Shelby’s future research on the use of A. terreus for biodegradation includes optimizing degradation conditions and assessing methods of application in the environment. Judging the 2025 Georgia BioGENEius Challenge were Ralph L. Cordell, CDC, and Alex Harvey, ViaMune. Cash prizes were awarded to Bhavya and Shelby. # # # About Georgia Life Sciences Georgia Life Sciences, founded in 1989, is a non-profit, membership-based organization that promotes the interests and growth of the life sciences industry. It is the state’s largest and most influential life sciences advocacy and business leadership organization working to improve access to innovative discoveries that have lifesaving impact. The association connects business, academia, government, and other allied entities involved in the application of life sciences products to fuel growth and collaboration through policy development, community programs, national industry initiatives, and a portfolio of educational and networking events. Learn more at galifesciences.org.
By Maria Thacker Goethe April 9, 2025
Emerging biotechnology is key for U.S. to remain dominant and secure future economic growth in a new era of global competition
MORE POSTS